about
Serology of Lupus Erythematosus: Correlation between Immunopathological Features and Clinical AspectsNitrated alpha-synuclein immunity accelerates degeneration of nigral dopaminergic neurons.Anti-dsDNA antibodies promote initiation, and acquired loss of renal Dnase1 promotes progression of lupus nephritis in autoimmune (NZBxNZW)F1 mice.Identification of autoreactive B cells with labeled nucleosomesC1 Complex: An Adaptable Proteolytic Module for Complement and Non-Complement FunctionsThe role of apoptosis in systemic lupus erythematosus.Remnants of suicidal cells fostering systemic autoaggression. Apoptosis in the origin and maintenance of autoimmunity.The neuropathology and pathogenesis of systemic lupus erythematosus.Pathogenesis of lupus.Triggers for anti-chromatin autoantibody production in SLE.Anti-chromatin antibodies in systemic lupus erythematosus: a useful marker for lupus nephropathy.Anti-dsDNA-NcX ELISA: dsDNA-loaded nucleosomes improve diagnosis and monitoring of disease activity in systemic lupus erythematosus.Inhibition of terminal complement: a novel therapeutic approach for the treatment of systemic lupus erythematosus.Lupus nephritis: an overview of recent findings.Pathogenic autoantibodies in lupus nephritis.Pathogenesis of lupus nephritis: an update.The impact of biological treatments on the anti-dsDNA and anti-nucleosome tests.Quantitation of autoantibodies in systemic autoimmune diseases: clinically useful?Lessons for lupus from tumour necrosis factor blockade.Induction of inflammatory and immune responses by HMGB1-nucleosome complexes: implications for the pathogenesis of SLEInduction of mucosal tolerance in SLE: a sniff or a sip away from ameliorating lupus?Nucleosomes and neutrophil activation in sickle cell disease painful crisis.Serum antinucleosome-specific antibody as a marker of autoimmunity in children with autism.Nuclease deficiencies promote end-stage lupus nephritis but not nephritogenic autoimmunity in (NZB × NZW) F1 mice.Chromatin as a target antigen in human and murine lupus nephritisThe spectrum of anti-chromatin/nucleosome autoantibodies: independent and interdependent biomarkers of disease.High occurrence of in vitro apoptosis of lymphocytes induced by serum from systemic lupus erythematosus patients is associated with increased serum levels of anti-C1q autoantibodies.Cell lines that express membrane-associated DNA for anti-DNA antibody detection.Cross-reaction of anti-DNA autoantibodies with membrane proteins of human glomerular mesangial cells in sera from patients with lupus nephritis.Enhanced activation of dendritic cells by autologous apoptotic microvesicles in MRL/lpr miceEffect of cytofectins on the immune response of murine macrophages to mammalian DNA.Time between onset of apoptosis and release of nucleosomes from apoptotic cells: putative implications for systemic lupus erythematosus.Anti-nucleosome antibody in sclerodema patients.Presence of antinucleosome autoantibodies in a restricted set of connective tissue diseases: antinucleosome antibodies of the IgG3 subclass are markers of renal pathogenicity in systemic lupus erythematosus.Testing for anti-nucleosome antibodies in daily practice: a monocentric evaluation in 1696 patients.Broad Susceptibility of Nucleolar Proteins and Autoantigens to Complement C1 Protease Degradation.Expansion of marginal zone B cells is not sufficient for the development of renal disease in NZBxNZW F1 mice.Autoantibodies, complement and type I interferon as biomarkers for personalized medicine in SLE.
P2860
Q27023280-B42D46AF-74A9-42C5-BE2E-1831EB903FDAQ33312931-9DA7357F-9008-4D45-9EB7-612FCE45E2AAQ33521279-569478AC-95A4-49D7-8665-E242AA90BD37Q33674468-69810028-4DAF-4AB5-BF81-14536DD8CE52Q33720322-E1C4DF1B-4C8B-4C1B-AC49-C4CE830AD8ABQ33787902-53FAF425-05D0-4B14-A113-BAD9FB82D2F0Q34004618-35A5F39C-E37A-49B9-B455-DDA23841B690Q34680879-1173177A-0381-43E0-AE7B-A04EAB0417FCQ34736475-062B4DF8-2642-4BA2-9E6C-024A19E3C882Q35045914-C3972840-4F94-4D37-B826-B8A572E3E9DCQ35552703-0B76FB78-2BDD-4BB0-8258-7BE636E5D142Q35620345-3CC023D4-5003-4AC7-AA8C-D7CC586658FDQ35824482-098FC481-D0BA-4581-A34F-84F4838EA49BQ35867038-844209C0-7C25-42DF-A012-7A47A792DDCFQ36054822-AC2E55DB-6A00-4094-A756-B8FC4B58F4C0Q36118530-84FD5698-3610-4B10-B0B7-67FD1D74DE9EQ36394266-DFD35B7F-A91A-4683-9A82-2852695A3C55Q36560767-9B833EC4-D69D-47AC-BEAF-93351BC509A0Q36677012-34D1122E-C92D-478D-9A47-DA73757B86EAQ37019629-79789439-39EA-4C96-864A-AD93CD7F230AQ37120570-28DDB977-F6D7-474E-8020-A536DCF85EB2Q37273218-EE5B796F-15EF-42B9-9030-DD42B7E00847Q37688416-0D0F8129-A980-40DE-86D5-DCD33D193F93Q37765141-71152AE2-B741-4A68-A2C3-88F22F44FA1EQ37872038-72609BBA-B83C-4C1B-9957-DC02E222CE5DQ38209945-5CE25367-6D27-4B99-9079-157FDE869F70Q39102596-9B09052F-766D-4E9C-84C3-0044A1DF5E0BQ39964403-E5DAE63A-7842-4D5F-A538-C111630205AAQ40263977-BEE676AD-4C90-4E4E-9EC7-67A1585D31F1Q40365709-C7634793-6392-4B2E-9E7A-3AD9D5BD7E1CQ40646535-F499C531-CB8B-4C99-9862-C5B6EE950A71Q41956989-80E9A605-84DE-472D-8C9E-3C6DCF74D40AQ42740166-3EF248ED-F6BF-4F7F-AA30-B5311EE38FDDQ43779444-E6011AF4-59D7-4F64-8F28-F88A0139814AQ47329854-B4930FF1-4905-43D1-A0A8-68556FE93CDAQ47603328-376037EE-6F8C-42DA-A18C-A472B9739587Q51044046-48BE1B71-5CA3-462F-9E0F-625DF2B9A86FQ51724948-BED8E69D-6AF8-4952-B976-322226476AA7
P2860
description
1999 nî lūn-bûn
@nan
1999 թուականի Մայիսին հրատարակուած գիտական յօդուած
@hyw
1999 թվականի մայիսին հրատարակված գիտական հոդված
@hy
1999年の論文
@ja
1999年学术文章
@wuu
1999年学术文章
@zh-cn
1999年学术文章
@zh-hans
1999年学术文章
@zh-my
1999年学术文章
@zh-sg
1999年學術文章
@yue
name
The key role of nucleosomes in lupus.
@ast
The key role of nucleosomes in lupus.
@en
type
label
The key role of nucleosomes in lupus.
@ast
The key role of nucleosomes in lupus.
@en
prefLabel
The key role of nucleosomes in lupus.
@ast
The key role of nucleosomes in lupus.
@en
P1476
The key role of nucleosomes in lupus.
@en
P2093
P2860
P304
P356
10.1002/1529-0131(199905)42:5<833::AID-ANR1>3.0.CO;2-T
P577
1999-05-01T00:00:00Z